News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
869,908 Results
Type
Article (87965)
Company Profile (825)
Press Release (781101)
Multimedia
Podcasts (195)
Webinars (28)
Section
Business (233262)
Career Advice (4147)
Deals (39878)
Drug Delivery (151)
Drug Development (91417)
Employer Resources (205)
FDA (18388)
Job Trends (17426)
News (397915)
Policy (39969)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3010)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (146)
Alliances (56981)
ALS (180)
Alzheimer's disease (1788)
Antibody-drug conjugate (ADC) (346)
Approvals (18562)
Artificial intelligence (622)
Autoimmune disease (157)
Automation (36)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (200)
Biotechnology (490)
Bladder cancer (162)
Brain cancer (65)
Breast cancer (659)
Cancer (5005)
Cardiovascular disease (440)
Career advice (3570)
Career pathing (41)
CAR-T (303)
CDC (59)
Celiac Disease (1)
Cell therapy (824)
Cervical cancer (37)
Clinical research (76984)
Collaboration (1792)
Company closure (5)
Compensation (1149)
Complete response letters (70)
COVID-19 (2991)
CRISPR (98)
C-suite (847)
Cystic fibrosis (154)
Data (6216)
Decentralized trials (2)
Denatured (71)
Depression (150)
Diabetes (530)
Diagnostics (7218)
Digital health (44)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (299)
Drug pricing (222)
Drug shortages (36)
Duchenne muscular dystrophy (239)
Earnings (100103)
Editorial (64)
Employer branding (25)
Employer resources (173)
Events (135041)
Executive appointments (1031)
FDA (21539)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1547)
Gene editing (214)
Generative AI (64)
Gene therapy (667)
GLP-1 (1120)
Government (5438)
Grass and pollen (8)
Guidances (385)
Healthcare (20943)
HIV (60)
Huntington's disease (49)
IgA nephropathy (86)
Immunology and inflammation (289)
Immuno-oncology (57)
Indications (91)
Infectious disease (3277)
Inflammatory bowel disease (205)
Inflation Reduction Act (17)
Influenza (119)
Intellectual property (244)
Interviews (816)
IPO (17954)
IRA (60)
Job creations (5199)
Job search strategy (2866)
JPM (66)
Kidney cancer (17)
Labor market (92)
Layoffs (659)
Leadership (40)
Legal (10160)
Liver cancer (98)
Longevity (14)
Lung cancer (676)
Lymphoma (377)
Machine learning (45)
Management (66)
Manufacturing (841)
MASH (172)
Medical device (15019)
Medtech (15067)
Mergers & acquisitions (22978)
Metabolic disorders (1386)
Multiple sclerosis (161)
NASH (23)
Neurodegenerative disease (352)
Neuropsychiatric disorders (96)
Neuroscience (3098)
Neurotech (1)
NextGen: Class of 2026 (7707)
Non-profit (5110)
Now hiring (64)
Obesity (671)
Opinion (335)
Ovarian cancer (166)
Pain (204)
Pancreatic cancer (230)
Parkinson's disease (297)
Partnered (39)
Patents (502)
Patient recruitment (471)
Peanut (60)
People (66881)
Pharmaceutical (145)
Pharmacy benefit managers (32)
Phase I (23793)
Phase II (33403)
Phase III (25175)
Pipeline (4902)
Policy (334)
Postmarket research (3554)
Preclinical (10691)
Press Release (72)
Prostate cancer (242)
Psychedelics (53)
Radiopharmaceuticals (298)
Rare diseases (887)
Real estate (7439)
Recruiting (80)
Regulatory (28970)
Reports (67)
Research institute (2722)
Resumes & cover letters (651)
Rett syndrome (27)
RNA editing (20)
RSV (83)
Schizophrenia (158)
Series A (256)
Series B (195)
Service/supplier (30)
Sickle cell disease (103)
Special edition (27)
Spinal muscular atrophy (176)
Sponsored (48)
Startups (4333)
State (2)
Stomach cancer (20)
Supply chain (112)
Tariffs (99)
The Weekly (122)
Vaccines (1142)
Venture capital (94)
Weight loss (461)
Women's health (85)
Worklife (21)
Date
Today (100)
Last 7 days (395)
Last 30 days (2270)
Last 365 days (32989)
2026 (2217)
2025 (33231)
2024 (38141)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (88)
Alaska (7)
Arizona (342)
Arkansas (14)
Asia (51540)
Australia (9047)
California (11475)
Canada (3297)
China (1156)
Colorado (486)
Connecticut (497)
Delaware (344)
Europe (118400)
Florida (1677)
Georgia (369)
Hawaii (4)
Idaho (68)
Illinois (957)
India (66)
Indiana (540)
Iowa (24)
Japan (425)
Kansas (133)
Kentucky (42)
Louisiana (29)
Maine (83)
Maryland (1450)
Massachusetts (8451)
Michigan (354)
Minnesota (662)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (126)
New Hampshire (85)
New Jersey (3088)
New Mexico (33)
New York (3034)
North Carolina (1603)
North Dakota (10)
Northern California (5480)
Ohio (352)
Oklahoma (22)
Oregon (54)
Pennsylvania (2297)
Puerto Rico (21)
Rhode Island (50)
South America (1661)
South Carolina (64)
South Dakota (1)
Southern California (4429)
Tennessee (175)
Texas (1808)
United States (41413)
Utah (344)
Vermont (1)
Virginia (289)
Washington D.C. (87)
Washington State (964)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
There are 869,908 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Rare diseases
REGENXBIO Delay Could Put Denali in Pole Position for Hunter Syndrome Approval
The discovery of a tumor in a patient who received REGENXBIO’s gene therapy for Hurler syndrome prompted the FDA to place a hold on that program along with the company’s Hunter syndrome program, which is awaiting an FDA decision on or before Feb. 8.
January 28, 2026
·
2 min read
·
Dan Samorodnitsky
Press Releases
Izotropic Provides Corporate Update & Announces Non-Brokered Private Placement
January 28, 2026
·
5 min read
Press Releases
Scryb Reports Fiscal 2025 Results; Strengthened Balance Sheet and Significant Cybeats Exposure
January 28, 2026
·
4 min read
Press Releases
Defence Therapeutics Expands Collaboration with Canadian Nuclear Laboratories to Accelerate Its Proprietary Radiopharmaceutical Pipeline
January 28, 2026
·
5 min read
Press Releases
InSysBio to announce a new collaborative project with BeOne Medicines
January 28, 2026
·
1 min read
Manufacturing
BMS-Partnered Cellares Raises $257M for Cell Therapy Manufacturing Expansion
Cellares, which last year became the first company to receive the FDA’s new advanced manufacturing technology designation, expects to support clinical production this year and offer commercial-scale manufacturing services in 2027.
January 28, 2026
·
2 min read
·
Nick Paul Taylor
Press Releases
Sensorion Announces €60 Million Financing With a €20M Strategic Investment from Sanofi and Support from Global Healthcare Specialists To Advance Genetic Medicine Pipeline
January 28, 2026
·
15 min read
Press Releases
Cantargia to Participate at Leerink Partners Global Healthcare Conference
January 28, 2026
·
1 min read
Press Releases
Fujirebio Expands Its Neuro Testing Portfolio With the Launch of the Fully Automated Lumipulse® G pTau 217 CSF Assay for Research Use Only
January 28, 2026
·
2 min read
Press Releases
Global expansion of Idorsia’s QUVIVIQ continues with EMS partnership for Latin America
January 28, 2026
·
6 min read
1 of 86,991
Next
